Subcutaneous Immunoglobulin (SCIG) Global Market Report 2024

Global Subcutaneous Immunoglobulin SCIG Market Report 2024

Subcutaneous Immunoglobulin (SCIG) Global Market Report 2024 – By Product Type (Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM)), By Application (Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurological Disorders, Other Applications), By End-Use (Clinics, Hospitals, Homecare, Other End-Uses) – Market Size, Trends, And Global Forecast 2024-2033

Name: Subcutaneous Immunoglobulin (SCIG) Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Subcutaneous Immunoglobulin (SCIG) Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : July 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Subcutaneous Immunoglobulin (SCIG) Global Market Report 2024

Proud Members Of

Subcutaneous Immunoglobulin (SCIG) Market Definition

Subcutaneous immunoglobulin (SCIG) refers to a method of administering immunoglobulin therapy in which the medication is delivered under the skin, rather than into a vein. This method allows for slower absorption of the medication, reducing the risk of side effects compared to intravenous administration. SCIG is used to treat various immune deficiencies, providing a convenient and effective way to boost the immune system.

The main types of subcutaneous immunoglobulin (SCIG) products include immunoglobulin A (IgA), immunoglobulin G (IgG), and immunoglobulin M (IgM). IgA is a type of antibody that plays a crucial role in immune defense at mucosal surfaces. It helps prevent pathogens from entering the body through mucosal membranes. They are used for several applications, such as primary immunodeficiency disorders, autoimmune diseases, neurological disorders, and others used by various end-users, including clinics, hospitals, homecare, and others.

Subcutaneous Immunoglobulin (SCIG) Market Segmentation

The subcutaneous immunoglobulin (SCIG) market covered in this report is segmented –

1) By Product Type: Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM)

2) By Application: Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurological Disorders, Other Applications

3) By End-Use: Clinics, Hospitals, Homecare, Other End-Uses

Global Subcutaneous Immunoglobulin SCIG Market Size 2023 to 2028: Graph

Subcutaneous Immunoglobulin (SCIG) Market Size 2024 And Growth Rate

The subcutaneous immunoglobulin market size has grown rapidly in recent years. It will grow from $11.19 billion in 2023 to $12.72 billion in 2024 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to the increased prevalence of immunodeficiency disorders, rise in the patient preference for home-based care, enhanced therapeutic efficacy, growth in the awareness and diagnosis rates, growth in the favorable reimbursement policies.

Subcutaneous Immunoglobulin (SCIG) Market Growth Forecast

The subcutaneous immunoglobulin market size is expected to see rapid growth in the next few years. It will grow to $21.38 billion in 2028 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to the growing prevalence of neurological disorders, increasing prevalence of autoimmune diseases, rising awareness and acceptance of immunoglobulin therapy, expanding applications in neurology and dermatology, expansion of healthcare facilities. Major trends in the forecast period include advancements in drug delivery systems, increasing demand for home infusion therapies, developments in antibody therapy, Innovations in formulations, and Innovations in SCIG.

Book your 30 minutes free consultation with our research experts

Subcutaneous Immunoglobulin (SCIG) Market Driver: Impact Of Secondary Immunodeficiency Diseases On The Subcutaneous Immunoglobulin Market

The increase in the prevalence of secondary immunodeficiency diseases is expected to propel the growth of the subcutaneous immunoglobulin market going forward. Secondary immunodeficiency diseases are conditions with a reduced or compromised immune system caused by sources other than the immune system itself. The prevalence of secondary immunodeficiency diseases is driven by various factors such as aging populations, the use of immunosuppressive treatments, and environmental toxins. Subcutaneous immunoglobulin therapy provides antibodies to help strengthen the weakened immune system, especially in chronic disorders such as HIV or autoimmune diseases, thereby preventing infections and supporting immunological function during treatment. For instance, in October 2023, according to the UK Health Security Agency, a UK-based government agency, reported 3,805 new HIV diagnoses in England in 2022, representing a 22% rise from the previous year. Therefore, the increase in the prevalence of secondary immunodeficiency diseases is driving the growth of the subcutaneous immunoglobulin market.

Rising Neurological Disorders Fuel Growth In The Subcutaneous Immunoglobulin Market

The increasing number of neurological disorders is expected to propel the growth of the subcutaneous immunoglobulin market going forward. A neurological disorder is any disorder of the nervous system that includes anatomical, biochemical, or electrical abnormalities in the brain, spinal cord, or peripheral nerves such as acute spinal cord injury, alzheimer's dementia, amyotrophic lateral sclerosis (ALS), ataxia, brain tumors, and others. Neurological disorders are increasing due to various factors such as aging populations, environmental toxins, genetic predispositions, and lifestyle changes. Subcutaneous immunoglobulin therapy can be beneficial in neurological disorders by providing antibodies that modulate the immune response, reduce inflammation, and stabilize neuromuscular junctions, potentially slowing disease progression and improving symptoms. For instance, in March 2022, according to the Alzheimer's Association, a US-based nonprofit voluntary health organization reported that 6.5 million Americans aged 65 and older are currently living with Alzheimer's dementia, with projections indicating this number could reach 13.8 million by 2060. Therefore, the increasing number of neurological disorders is driving the growth of the subcutaneous immunoglobulin market.

Global Subcutaneous Immunoglobulin (SCIG) Market Major Players

Major companies operating in the subcutaneous immunoglobulin (SCIG) market are Pfizer Inc., Johnson & Johnson, Prothena Corporation plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Baxter International Inc., CSL Behring, Lonza Group, Grifols S.A., Octapharma AG, Dr. Reddy's Laboratories, Intas pharmaceutical Ltd., Emergent BioSolutions Inc., Kedrion Biopharma, LFB group, Biotest AG, Argenx SE, Bio Products Laboratory Ltd., ADMA Biologics Inc., Sino Biological Inc., Bharat Serums and Vaccines Limited (BSV), Kamada Pharmaceuticals, CinnaGen Co., Shire plc

Global Subcutaneous Immunoglobulin (SCIG) Market Trend: Advancements In Subcutaneous Immunoglobulin Therapy For Primary Immunodeficiency Diseases

Major companies operating in the subcutaneous immunoglobulin market are developing subcutaneous human-klhw, a unique formulation containing human immune globulins (Ig) that strengthens the immune system. Subcutaneous human-klhw is used for subcutaneous administration, developed for treating primary immunodeficiency diseases in human body. For instance, in March 2022, Grifols S.A., a Spain-based pharmaceutical company, launched XEMBIFY 20% subcutaneous immunoglobulin (SCIG). It is specifically designed to treat primary immunodeficiency, meeting a significant medical need for people with weakened immune systems. XEMBIFY is a ready-to-use formulation that simplifies the treatment process and increases patient convenience. It is stable at room temperature for up to 24 months, avoiding the need for refrigeration during storage and transportation, which can be extremely useful in a variety of healthcare settings.

Regional Insights For The Global Subcutaneous Immunoglobulin (SCIG) Market

North America was the largest region in the subcutaneous immunoglobulin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the subcutaneous immunoglobulin (SCIG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the subcutaneous immunoglobulin (SCIG) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The subcutaneous immunoglobulin (SCIG) market consists of revenues earned by entities by providing services such as immune system support, home-based therapy, infection prevention, personalized dosing, patient training, and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The subcutaneous immunoglobulin market also includes sales of infusion pumps, needles and catheters, syringes, and sharps disposal containers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The subcutaneous immunoglobulin (SCIG) market research report is one of a series of new reports from The Business Research Company that provides subcutaneous immunoglobulin (SCIG) market statistics, including the subcutaneous immunoglobulin (SCIG) industry global market size, regional shares, competitors with subcutaneous immunoglobulin (SCIG) market share, detailed subcutaneous immunoglobulin (SCIG) market segments, market trends, and opportunities, and any further data you may need to thrive in the subcutaneous immunoglobulin (SCIG) industry. These subcutaneous immunoglobulin (SCIG) market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Subcutaneous Immunoglobulin (SCIG) Market Report Forecast and Analysis

Report Attribute	Details
Market Size Value In 2024	$12.72 billion
Revenue Forecast In 2033	$21.38 billion
Growth Rate	CAGR of 13.9% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Product Type: Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM) 2) By Application: Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurological Disorders, Other Applications 3) By End-Use: Clinics, Hospitals, Homecare, Other End-Uses
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson, Prothena Corporation plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Baxter International Inc., CSL Behring, Lonza Group, Grifols S.A., Octapharma AG, Dr. Reddy's Laboratories, Intas pharmaceutical Ltd., Emergent BioSolutions Inc., Kedrion Biopharma, LFB group, Biotest AG, Argenx SE, Bio Products Laboratory Ltd., ADMA Biologics Inc., Sino Biological Inc., Bharat Serums and Vaccines Limited (BSV), Kamada Pharmaceuticals, CinnaGen Co., Shire plc
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Subcutaneous Immunoglobulin (SCIG) Market Characteristics

3. Subcutaneous Immunoglobulin (SCIG) Market Trends And Strategies

4. Subcutaneous Immunoglobulin (SCIG) Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Subcutaneous Immunoglobulin (SCIG) Market Size and Growth

5.1. Global Subcutaneous Immunoglobulin (SCIG) Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Subcutaneous Immunoglobulin (SCIG) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Subcutaneous Immunoglobulin (SCIG) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Subcutaneous Immunoglobulin (SCIG) Market Segmentation

6.1. Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Immunoglobulin A (IgA)

Immunoglobulin G (IgG)

Immunoglobulin M (IgM)

6.2. Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Primary Immunodeficiency Disorders

Autoimmune Diseases

Neurological Disorders

Other Applications

6.3. Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Clinics

Hospitals

Homecare

Other End-Uses

7. Subcutaneous Immunoglobulin (SCIG) Market Regional And Country Analysis

7.1. Global Subcutaneous Immunoglobulin (SCIG) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Subcutaneous Immunoglobulin (SCIG) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market

8.1. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Subcutaneous Immunoglobulin (SCIG) Market

9.1. China Subcutaneous Immunoglobulin (SCIG) Market Overview

9.2. China Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Subcutaneous Immunoglobulin (SCIG) Market

10.1. India Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Subcutaneous Immunoglobulin (SCIG) Market

11.1. Japan Subcutaneous Immunoglobulin (SCIG) Market Overview

11.2. Japan Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Subcutaneous Immunoglobulin (SCIG) Market

12.1. Australia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Subcutaneous Immunoglobulin (SCIG) Market

13.1. Indonesia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Subcutaneous Immunoglobulin (SCIG) Market

14.1. South Korea Subcutaneous Immunoglobulin (SCIG) Market Overview

14.2. South Korea Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Subcutaneous Immunoglobulin (SCIG) Market

15.1. Western Europe Subcutaneous Immunoglobulin (SCIG) Market Overview

15.2. Western Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Subcutaneous Immunoglobulin (SCIG) Market

16.1. UK Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Subcutaneous Immunoglobulin (SCIG) Market

17.1. Germany Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Subcutaneous Immunoglobulin (SCIG) Market

18.1. France Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Subcutaneous Immunoglobulin (SCIG) Market

19.1. Italy Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Subcutaneous Immunoglobulin (SCIG) Market

20.1. Spain Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market

21.1. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market Overview

21.2. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Subcutaneous Immunoglobulin (SCIG) Market

22.1. Russia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Subcutaneous Immunoglobulin (SCIG) Market

23.1. North America Subcutaneous Immunoglobulin (SCIG) Market Overview

23.2. North America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Subcutaneous Immunoglobulin (SCIG) Market

24.1. USA Subcutaneous Immunoglobulin (SCIG) Market Overview

24.2. USA Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Subcutaneous Immunoglobulin (SCIG) Market

25.1. Canada Subcutaneous Immunoglobulin (SCIG) Market Overview

25.2. Canada Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Subcutaneous Immunoglobulin (SCIG) Market

26.1. South America Subcutaneous Immunoglobulin (SCIG) Market Overview

26.2. South America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Subcutaneous Immunoglobulin (SCIG) Market

27.1. Brazil Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Subcutaneous Immunoglobulin (SCIG) Market

28.1. Middle East Subcutaneous Immunoglobulin (SCIG) Market Overview

28.2. Middle East Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Subcutaneous Immunoglobulin (SCIG) Market

29.1. Africa Subcutaneous Immunoglobulin (SCIG) Market Overview

29.2. Africa Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Subcutaneous Immunoglobulin (SCIG) Market Competitive Landscape And Company Profiles

30.1. Subcutaneous Immunoglobulin (SCIG) Market Competitive Landscape

30.2. Subcutaneous Immunoglobulin (SCIG) Market Company Profiles

30.2.1. Pfizer Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Johnson & Johnson

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Prothena Corporation plc

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. GlaxoSmithKline plc

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Takeda Pharmaceutical Company Limited

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Subcutaneous Immunoglobulin (SCIG) Market Other Major And Innovative Companies

31.1. Amgen Inc.

31.2. Baxter International Inc.

31.3. CSL Behring

31.4. Lonza Group

31.5. Grifols S.A.

31.6. Octapharma AG

31.7. Dr. Reddy's Laboratories

31.8. Intas pharmaceutical Ltd.

31.9. Emergent BioSolutions Inc.

31.10. Kedrion Biopharma

31.11. LFB group

31.12. Biotest AG

31.13. Argenx SE

31.14. Bio Products Laboratory Ltd.

31.15. ADMA Biologics Inc.

32. Global Subcutaneous Immunoglobulin (SCIG) Market Competitive Benchmarking

33. Global Subcutaneous Immunoglobulin (SCIG) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Subcutaneous Immunoglobulin (SCIG) Market

35. Subcutaneous Immunoglobulin (SCIG) Market Future Outlook and Potential Analysis

35.1 Subcutaneous Immunoglobulin (SCIG) Market In 2028 - Countries Offering Most New Opportunities

35.2 Subcutaneous Immunoglobulin (SCIG) Market In 2028 - Segments Offering Most New Opportunities

35.3 Subcutaneous Immunoglobulin (SCIG) Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Subcutaneous Immunoglobulin (SCIG) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Subcutaneous Immunoglobulin (SCIG) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Asia-Pacific, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: China, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: India, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: Japan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Australia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Indonesia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: South Korea, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: Western Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: UK, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: Germany, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: France, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: Italy, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Spain, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Eastern Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Russia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: North America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: USA, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: Canada, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: South America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: Brazil, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Middle East, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Africa, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Pfizer Inc. Financial Performance

Table 75: Johnson & Johnson Financial Performance

Table 76: Prothena Corporation plc Financial Performance

Table 77: GlaxoSmithKline plc Financial Performance

Table 78: Takeda Pharmaceutical Company Limited Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Subcutaneous Immunoglobulin (SCIG) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Subcutaneous Immunoglobulin (SCIG) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Asia-Pacific, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: China, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: India, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: Japan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Australia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Indonesia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: South Korea, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: Western Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: UK, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: Germany, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: France, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: Italy, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Spain, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Eastern Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Russia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: North America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: USA, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: Canada, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: South America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: Brazil, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Middle East, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Africa, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Pfizer Inc. Financial Performance

Figure 75: Johnson & Johnson Financial Performance

Figure 76: Prothena Corporation plc Financial Performance

Figure 77: GlaxoSmithKline plc Financial Performance

Figure 78: Takeda Pharmaceutical Company Limited Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth

Digital Immune System Global Market Report 2024 – By Component (Solution, Services), By Deployment Model (On-Premises, Cloud), By Security Type (Network Security, Cloud Security, Endpoint Security, Internet of Things (IoT) Security, Other Security Types), By End User (Information Technology And Telecom, Banking, Financial Services, And Insurance, Manufacturing, Healthcare, Government And Defense, Retail And E-commerce, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Immunoglobulin E (IgE) Allergy Blood Tests Global Market Report 2024 – By Product Type (Assays And Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Testing Kits, Fluorescent Enzyme Immunoassays (FEIA) Testing Kits, Chemiluminescent Immunoassays (CLIA), Reagents, Consumables, Analyzers), By Application (Aero Allergies, Indoor Allergies, Outdoor Allergies, Food Allergies, Venoms, Medicine Allergies, Latex/Metal Allergies), By End User (Diagnostic Laboratories, Specialty Clinics, Hospitals, Research And Academic Centers) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Autoimmune Treatment Global Market Report 2024 – By Product (Consumables and Assay Kits, Instruments, Services), By Service Type (Consultation and Diagnosis, Therapy and monitoring, Drug development), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases), By Drug Class (Anti-Inflammatory, Anti-Hyperglycemic, NSAIDs, Interferons, Other Drug Class), By End User (Clinical Laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Immune Health Supplements Global Market Report 2024 – By Ingredients Type( Vitamins, Minerals, Herbal Botanical Extracts, Probiotics, Amino Acids, Omega 3 - Fatty Acids), By Form( Soft Gels Or Capsules, Tablets, Powder, Liquid, Other Forms), By Source Type( Plant-Based, Animal-Based), By Distribution Channel( Pharmacies and Drug Stores, Hypermarket or Supermarket, Online Stores, Specialty Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Global Market Report 2024 – By Product (Nivolumab, Pembrolizumab, Atezolizumab, Avelumab, Durvalumab), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), By Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin Lymphoma, Colorectal Cancer, Other Applications), By End-Users (Hospitals, Specialty Clinics, Academic and Research Institutions) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Autoimmune Disease Diagnosis Global Market Report 2024 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals, Others), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Immunoglobulins Global Market Report 2024 – By Product (IGG, IGA, IGM, IGE, IGD. ), By Mode Of Delivery (Intravenous Mode of Delivery, Subcutaneous Mode of Delivery), By Application (Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Intravenous Immunoglobulin Global Market Report 2024 – By Type( IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)), By Distribution Channel( Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels ), By Application( Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications ), By End-User( Hospitals, Clinics, Home Care) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the market?

How will the market drivers and restraints affect the market dynamics? What forces will shape the industry going forward?

The market major growth driver - The subcutaneous immunoglobulin market size has grown rapidly in recent years. It will grow from $11.19 billion in 2023 to $12.72 billion in 2024 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to the increased prevalence of immunodeficiency disorders, rise in the patient preference for home-based care, enhanced therapeutic efficacy, growth in the awareness and diagnosis rates, growth in the favorable reimbursement policies. The subcutaneous immunoglobulin market size is expected to see rapid growth in the next few years. It will grow to $21.38 billion in 2028 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to the growing prevalence of neurological disorders, increasing prevalence of autoimmune diseases, rising awareness and acceptance of immunoglobulin therapy, expanding applications in neurology and dermatology, expansion of healthcare facilities. Major trends in the forecast period include advancements in drug delivery systems, increasing demand for home infusion therapies, developments in antibody therapy, Innovations in formulations, and Innovations in SCIG.. For further insights on the market, request a sample here

What is the forecast market size or the forecast market value of the market?

The subcutaneous immunoglobulin market size has grown rapidly in recent years. It will grow from $11.19 billion in 2023 to $12.72 billion in 2024 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to the increased prevalence of immunodeficiency disorders, rise in the patient preference for home-based care, enhanced therapeutic efficacy, growth in the awareness and diagnosis rates, growth in the favorable reimbursement policies. The subcutaneous immunoglobulin market size is expected to see rapid growth in the next few years. It will grow to $21.38 billion in 2028 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to the growing prevalence of neurological disorders, increasing prevalence of autoimmune diseases, rising awareness and acceptance of immunoglobulin therapy, expanding applications in neurology and dermatology, expansion of healthcare facilities. Major trends in the forecast period include advancements in drug delivery systems, increasing demand for home infusion therapies, developments in antibody therapy, Innovations in formulations, and Innovations in SCIG. For further insights on the market, request a sample here

How is the market segmented?

The market is segmented
1) By Product Type: Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM)
2) By Application: Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurological Disorders, Other Applications
3) By End-Use: Clinics, Hospitals, Homecare, Other End-UsesFor further insights on the market, request a sample here

Which region has the largest share of the market? What are the other regions covered in the report?

North America was the largest region in the subcutaneous immunoglobulin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the subcutaneous immunoglobulin (SCIG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on the market, request a sample here.

Major companies operating in the subcutaneous immunoglobulin (SCIG) market are Pfizer Inc., Johnson & Johnson, Prothena Corporation plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Baxter International Inc., CSL Behring, Lonza Group, Grifols S.A., Octapharma AG, Dr. Reddy's Laboratories, Intas pharmaceutical Ltd., Emergent BioSolutions Inc., Kedrion Biopharma, LFB group, Biotest AG, Argenx SE, Bio Products Laboratory Ltd., ADMA Biologics Inc., Sino Biological Inc. , Bharat Serums and Vaccines Limited (BSV), Kamada Pharmaceuticals, CinnaGen Co., Shire plc For further insights on the market, request a sample here.

What are the key trends in the market?

Major trend in the market - Advancements In Subcutaneous Immunoglobulin Therapy For Primary Immunodeficiency Diseases. For further insights on the market, request a sample here.

What are the major opportunities in the market? What are the strategies for the market?

For detailed insights on the major opportunities and strategies in the market, request a sample here.

How does the market relate to the overall economy and other similar markets?

For detailed insights on market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the industry?

For detailed insights on the mergers and acquisitions in the industry, request a sample here.

What are the key dynamics influencing the market growth? SWOT analysis of the market.

For detailed insights on the key dynamics influencing the market growth and SWOT analysis of the industry, request a sample here.